AI-Ready Bio-Data Standards Act
- Bill Number
- S. 4069
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 2
- Policy Area
- Science, Technology, Communications
- Status
- Introduced
- Latest Action
- 2026-03-12: Read twice and referred to the Committee on Commerce, Science, and Transportation.
- Last Updated
- 2026-04-02T17:59:35Z
AI-Generated Summary
Purpose
The AI-Ready Bio-Data Standards Act aims to improve the quality and usability of biological data (information about living systems, like genes or proteins) generated from federally funded research. It directs the National Institute of Standards and Technology (NIST, a government agency that develops standards for technology and science) to create guidelines ensuring this data is formatted and prepared for training artificial intelligence (AI) models. This supports advancements in biotechnology (tech using living organisms) and AI applications, such as drug discovery or medical research.
Key Provisions
- Definitions and Standards: NIST must define key terms like "artificial intelligence-ready" (data formatted for easy AI use, including negative data that doesn't support a hypothesis but still adds knowledge), "biomanufacturing" (producing products using biological processes), "biotechnology," and "qualified federally funded research" (federal research grants meeting criteria like funding amount, researcher expertise, and data size). It will also set standards for preparing biological datasets (collections of biological data) to be AI-ready.
- Resources and Frameworks: NIST will develop tools for data management and cybersecurity, targeted at federal agencies funding research and researchers collecting or cleaning data. These must avoid excessive burdens on funded researchers.
- Inventory and Public Access: Within one year, NIST will catalog existing biotech standards and datasets from federal funding, then publish this on its website.
- Testing and Evaluation: NIST, with the National Science Foundation, will test the guidelines every two years on sample datasets to check clarity, ease of use, and burden on researchers, making adjustments as needed.
- Agency Policies: Within two years, NIST will create or update data policies for agencies like the Departments of Agriculture, Defense, and Energy; NASA; NIH; and NSF. These include funding mechanisms for compliance, designating compliance officers, a public repository of policies, a database for sharing AI-ready datasets, reporting tools, and assistance requests.
- Consultation and Advisory Group: NIST must seek public input, consult biotech/AI industries, academia, and agencies. An advisory group of at least 12 members (from agencies, academia, private sector, and publishers) will provide recommendations, review policies, and advise journals on AI-ready data guidelines. Members serve two-year terms, with reports to NIST.
- Regulatory and Reporting Updates: The Federal Acquisition Regulation (rules for government contracts) will be revised to enforce these standards. NIST submits annual reports to Congress on progress, including a cost-benefit analysis of burdens vs. benefits. The Government Accountability Office will report on impacts after five years.
- Timeline and Sunset: Initial establishment within two years; annual updates. The law ends after 10 years.
Significant Changes to Existing Law
This bill introduces new federal requirements for biological data from qualified research grants, mandating AI-readiness where none existed before. It builds on existing data-sharing policies (e.g., from NIH or NSF) by adding specific AI-focused standards, cybersecurity frameworks, and agency-specific enforcement. It also creates novel elements like a public database for AI-ready datasets and an advisory group for ongoing input, without altering core funding laws but integrating AI preparation into grant conditions via procurement rules.
Potential Impacts
- Government Agencies: Increases administrative work for funding agencies to adopt policies, designate officers, and report compliance, but provides tools for better data reuse in AI-driven research. Could lead to more efficient federal investments in biotech.
- Citizens and Researchers: Funded scientists (e.g., in universities or labs) gain standardized resources but face new data formatting requirements, potentially slowing some projects if burdensome. Broader benefits include faster AI advancements in health, agriculture, and defense, leading to innovations like better vaccines or sustainable crops.
- International Relations: Positions the U.S. as a leader in AI-biotech integration, potentially influencing global standards and encouraging international collaboration, though it may raise data-sharing concerns with foreign partners.
Main Stakeholders Affected
- Federal Agencies: NIST (lead implementer), NIH, NSF, Departments of Agriculture, Defense, and Energy, NASA (funders of biotech research).
- Researchers and Academia: Recipients of federal grants, including university scientists generating biological data.
- Private Sector: Biotech and AI companies (for consultation and potential data access), academic publishers (for journal guidelines).
- Public: Benefits from accessible, high-quality data advancing science; indirect input via feedback mechanisms.
Notable Legal, Constitutional, or Political Implications
- Legal: Reinforces open data principles in federal research without mandating private sector compliance, avoiding antitrust issues. The 10-year sunset allows periodic review to ensure relevance. Discretion for NIST to deem data non-AI-ready (e.g., for security) provides flexibility but could invite challenges if seen as arbitrary.
- Constitutional: Aligns with Congress's spending power to condition federal grants, promoting general welfare through science advancement; no apparent free speech or privacy conflicts, as it focuses on funded public research data.
- Political: Bipartisan introduction (by Sens. Young and Lujan) signals broad support for AI-biotech synergy amid U.S. competition with China. Emphasizes burden reduction to appeal to researchers, but implementation costs could spark debates on federal overreach in science funding.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (1)
Recent Actions
- 2026-03-12: Read twice and referred to the Committee on Commerce, Science, and Transportation.
- 2026-03-12: Introduced in Senate
Bill Versions
- AI-Ready Bio-Data Standards Act — issued 2026-03-12 — PDF (18 pages)